Purpose Low-grade glioma (LGG) patients may face health-related quality-of-life (HRQoL)
impairments, due to the tumour, treatment and associated side-effects and prospects of …

When radiotherapy is used in the treatment of head and neck cancers, the brain commonly
receives incidental doses of radiotherapy with potential for neurocognitive changes and …

Background Impairments in neurocognitive functioning (NCF) frequently occur in glioma
patients. Both the tumor and its treatment contribute to these impairments. We aimed to …

Purpose Deficits in neurocognitive functioning (NCF) frequently occur in glioma patients.
Both treatment and the tumor itself contribute to these deficits. In order to minimize the …

Incidence of primary CNS lymphoma (PCNSL) is increasing, while prognosis is improving as
treatments advance. However, declined cognitive functioning remains a major challenge in …

Health related quality of life (HRQoL) has become an important consideration in LGG
patients. We report the largest prospective, longitudinal, cross-sectional cohort study of …

Cognitive performance influences the quality of life and survival of people with glioma. Thus,
a detailed neuropsychological and language evaluation is essential. In this work, we tested …

Background Neurocognitive function of adult patients with brain tumours may deteriorate
after radiotherapy. Proton beam therapy (PBT) reduces the volume of irradiated healthy …

Simple Summary Low-grade gliomas (LGGs) comprise 13–16% of glial tumors. As survival
for LGG patients has been improving, it is important to consider the effects of diagnosis and …

Purpose Clinical trials in glioma patients with neurocognitive deficits face challenges due to
lacking or unreliable patient self-reports on their health-related quality of life (HRQOL) …